Newborn genetic screening for spinal muscular atrophy in the UK : the views of the general population\ud

Article English OPEN
Boardman, Felicity K.; Sadler, Chloe; Young, Philip J.;
(2018)

Background: \ud \ud Spinal muscular atrophy (SMA) is an inherited neuromuscular disorder and a leading genetic cause of infant death worldwide. However, there is no routinescreening programme for SMA in the UK. Lack of treatments, and the inability of the screening test... View more
  • References (51)
    51 references, page 1 of 6

    Ar Rochmah, M., Harahap, N. I. F., Niba, E. T. E., Nakanishi, K., Awano, H., Morioka, I., . . . Shinohara, M. (2017). Genetic screening of spinal muscular atrophy using a real-time modified COPPCR technique with dried blood-spot DNA. Brain Development, 39(9), 774-782. https://doi.org/10.1016/j.braindev.2017.04.015

    Bailey, D. B., Skinner, D., Davis, A. M., Whitmarsh, I., & Powell, C. (2008). Ethical, legal, and social concerns about expanded newborn screening: Fragile x syndrome as a prototype for emerging issues. Pediatrics, 121(3), e693-e704. https://doi.org/10.1542/ped s.2007-0820

    Bertini, E., Hwu, P., Reyna, S., Farwell, W., & De, D. (2017). Phase 2 study design of antisense oligonucleotide nusinersen in presymptomatic infants with spinal muscular atrophy. Neuromuscular Disorders, 26(2), S210.

    Boardman, F. (2010). The role of experiential knowledge in the reproductive decision making of families genetically at risk: the case of Spinal Muscular Atrophy, University of Warwick: Department of Sociology.

    Boardman, F. (2017). The role of experiential knowledge within attitudes towards genetic carrier screening: A comparison of people with and without experience of spinal muscular atrophy. Health Expectations, 1-11. https://doi.org/10.1111/hex.12602

    Boardman, F. K., Young, P. J., & Griffiths, F. E. (2017a). Impairment experiences, identity and attitudes towards genetic screening: The views of people with spinal muscular atrophy. Journal of Genetic Counseling, https://doi.org/10.1007/s10897-017-0122-7

    Boardman, F. K., Young, P. J., & Griffiths, F. E. (2017b). Newborn screening for spinal muscular atrophy: The views of affected families and adults. American Journal of Medical Genetics, Part A, 173(6), 1546-1561. https://doi.org/10.1002/ajmg.a.38220

    Boardman, F. K., Young, P. J., & Griffiths, F. E. (2017c). Population screening for spinal muscular atrophy: A mixed methods study of the views of affected families. American Journal of Medical Genetics, Part A, 173(2), 421-434. https://doi.org/10.1002/ajmg.a.38031

    Bombard, Y., Miller, F., Hayeems, R., Avard, D., Knoppers, B., Cornel, M., & Borry, P. (2009). The expansion of newborn screening: Is reproductive benefit an appropriate pursuit?. Nature Review Genetics, 10, 666-667. https://doi.org/10.1038/nrg2666

    Botkin, J. R., & Rothwell, E. (2016). Whole genome sequencing and newborn screening. Current Genetic Medicine Reports, 4(1), 1-6.

  • Metrics
Share - Bookmark